The Pink Pill: Why Women Had to Fight the FDA

madman · 2026-03-29T11:28:02-0500

What happens when women have to fight to be heard in medicine?

In this episode, we’re breaking down The Pink Pill — a powerful documentary that follows the long, complicated journey of getting Addyi (flibanserin) approved for women with low sexual desire.We talk about:

the fight behind FDA approval
bias in women’s healthcare
why desire is still misunderstood
and what this story reveals about the system as a whole

This isn’t just about one medication — it’s about who gets believed, who gets studied, and who gets access to care.

Chapters

00:00 Introduction to The Pink Pill Documentary
02:00 The Journey of Flibanserin's Approval
07:46 The Fight for Women's Sexual Health
11:48 Bias in Medical Approval Processes
15:48 Understanding Women's Sexual Desire
21:12 Audience Reactions and Empowerment
24:20 Owning Pleasure and Advocating for Health

madman · 2026-03-29T11:28:58-0500

Thread 'The Little Pink Pill & The Big Fight for Women’s Sexual Health'

Sep 29, 2025

Cindy Eckert, CEO and Founder of Sprout Pharmaceuticals, made history by bringing Addyi — the first and only FDA-approved drug for hypoactive sexual desire disorder (HSDD) in women, also known as low libido — to market. In 2015, Eckert sold Sprout Pharmaceuticals for a record-breaking $1 billion. She later fought to reacquire the company and reclaim control of Addyi to continue her mission of breaking down barriers in women’s sexual health and fighting for gender equity in healthcare.

In today’s conversation, Cindy shares her relentless mission to address...